The burgeoning field of obesity management has witnessed remarkable advancements with the emergence of dual GLP-3 receptor agonists, notably Retatrutide and Trizepatide. These innovative therapies represent a https://margiesunp606767.blogpixi.com/39021743/glp-3-receptor-agonists-retatrutide-trizepatide